Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerstin Lorenz

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Innere Medizin (Heidelberg, Germany)|June 18, 2024
[Endocrine oncology : An update on surgical treatments]Kerstin Lorenz
Therapeutische Umschau. Revue Therapeutique|November 4, 2020
[Surgical aspects of multiple endocrine neoplasia type 2]Kerstin Lorenz, Ilker Satiroglu
Wiener Klinische Wochenschrift|November 7, 2007
Surgical treatment of sporadic gastrinomaKerstin Lorenz, Henning Dralle
Chirurgie (Heidelberg, Germany)|May 19, 2025
[Update on medullary thyroid carcinoma-What is relevant for surgeons?]Kerstin Lorenz, Andreas Machens, Henning Dralle
The Journal of Clinical Endocrinology and Metabolism|December 4, 2013
Progression of medullary thyroid cancer in RET carriers of ATA class A and C mutationsAndreas Machens, Kerstin Lorenz, Henning Dralle
The Journal of Clinical Endocrinology and Metabolism|January 4, 2013
Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screeningAndreas Machens, Kerstin Lorenz, Henning Dralle
The Journal of Clinical Endocrinology and Metabolism|May 21, 2014
Utility of serum procalcitonin for screening and risk stratification of medullary thyroid cancerAndreas Machens, Kerstin Lorenz, Henning Dralle
Endocrine|June 8, 2026
RET p.Cys634-driven progression of hereditary vs. sporadic medullary thyroid cancerAndreas Machens, Kerstin Lorenz, Henning Dralle
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 20, 2017
Parathyroid Hormone Levels Predict Long-Term Outcome After Operative Management of Parathyroid CancerAndreas Machens, Kerstin Lorenz, Henning Dralle
Chirurgie (Heidelberg, Germany)|January 12, 2024
[Individualization of treatment in sporadic and hereditary medullary thyroid cancer]Kerstin Lorenz, Andreas Machens, Henning Dralle
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Innere Medizin (Heidelberg, Germany)|June 18, 2024
[Endocrine oncology : An update on surgical treatments]Kerstin Lorenz
Therapeutische Umschau. Revue Therapeutique|November 4, 2020
[Surgical aspects of multiple endocrine neoplasia type 2]Kerstin Lorenz, Ilker Satiroglu
Wiener Klinische Wochenschrift|November 7, 2007
Surgical treatment of sporadic gastrinomaKerstin Lorenz, Henning Dralle
Chirurgie (Heidelberg, Germany)|May 19, 2025
[Update on medullary thyroid carcinoma-What is relevant for surgeons?]Kerstin Lorenz, Andreas Machens, Henning Dralle
The Journal of Clinical Endocrinology and Metabolism|December 4, 2013
Progression of medullary thyroid cancer in RET carriers of ATA class A and C mutationsAndreas Machens, Kerstin Lorenz, Henning Dralle
The Journal of Clinical Endocrinology and Metabolism|January 4, 2013
Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screeningAndreas Machens, Kerstin Lorenz, Henning Dralle
The Journal of Clinical Endocrinology and Metabolism|May 21, 2014
Utility of serum procalcitonin for screening and risk stratification of medullary thyroid cancerAndreas Machens, Kerstin Lorenz, Henning Dralle
Endocrine|June 8, 2026
RET p.Cys634-driven progression of hereditary vs. sporadic medullary thyroid cancerAndreas Machens, Kerstin Lorenz, Henning Dralle
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 20, 2017
Parathyroid Hormone Levels Predict Long-Term Outcome After Operative Management of Parathyroid CancerAndreas Machens, Kerstin Lorenz, Henning Dralle
Chirurgie (Heidelberg, Germany)|January 12, 2024
[Individualization of treatment in sporadic and hereditary medullary thyroid cancer]Kerstin Lorenz, Andreas Machens, Henning Dralle
Pageof 13